This surprisingly beneficial compound found in certain species of mushrooms has been underestimated medically for decades and now is the right time to start exploring it in all its glory.
This view is thankfully also shared by many scientists and open-minded authors, most notable being the Johns Hopkins University’s professor of Psychiatry and Neurosciences Dr. Roland R. Griffiths, who took matters into his own hands and started exploring this “magical” substance.
He and his team conducted a number of studies in order to figure out how us humans can benefit from psilocybin — a psychedelic substance found in what we now know as magic mushrooms.
Apparently, the history of human use of psilocybin goes way back to the prehistoric era. Rock drawings from some 6,000 years ago are believed to be made under the influence of magic mushrooms, but it wasn’t until the 1950’s that science and mainstream media brought psilocybin into the spotlight.
This newfound surge of interest for psilocybin paved the way for Dr. Griffiths to show us that this compound is not that of a monster drug after all.
And you are going to be surprised what this little compound can do for our wellbeing
Goodbye depression, goodbye anxiety
Dr. Griffiths found something that could be a game changer in the world of psychiatry: in his pilot study, he noticed that psilocybin was not only helping the brain block depression, but that its effects last for up to six months.
What researchers did first was they gathered a group of 56 adults diagnosed with life-threatening cancer, and gave them two doses of psilocybin (low, and afterwards moderate-high) during two separate sessions.
They monitored patients’ mood, behavior, as well as depression and anxiety symptoms before, during and after psilocybin treatment. Researchers were amazed by the results as there was an immediate reduction in anxiety and depression.
All the more, after a six-month period, 80 percent of participants were still showing a reduction in anxiety and depression.
And this is important since one dose of psilocybin can replace a six-month antidepressant therapy and help ease the struggles the terminally-ill patients have to endure.
Solution for substance abuse?
Another very promising aspect of psilocybin is that it can help heavy and long-term smokers quit their bad habit.
The researchers from Johns Hopkins University conducted a very simple research in which 15 participants with nicotine addiction had three psilocybin sessions.
Twelve months after taking psilocybin, 67% of participants completely quit smoking and 87% said that psilocybin was one of the most “meaningful and spiritually significant experiences of their lives”.
This could be a huge thing in the future as many other addictions share neurological pathways similar to smoking, so if properly researched, many lives could be saved with just one right dose of psilocybin.
Resetting the brain
It looks like even the untreatable depression can be cured with nothing other than a chemical found in psilocybe mushrooms. In fact, after taking psilocybin, certain parts of our brain are way better and more connected with each other, thus creating a more clear and affirmative view on life.
This could be particularly helpful when dealing with our fears and obsessions. Psilocybin could be the quick solution to overcoming painful memories and a hope for many PTSD patients.
It’s time for new adventures
Yes, just one magic mushroom experience is enough to change your point of view, and in a good way of course. These kind of changes in personality are rare after we turn 20, but apparently, it’s possible to see long-term changes after just one session.
Being open to new ideas, experiences and other people’s views is something that some individuals have difficulty achieving, however, psilocybin can elevate and trigger your curiosity to completely new levels.
In order to have a pleasant psychedelic experience and avoid “bad tripping”, be responsible to yourself and other people, take the right dose and do your research before taking shrooms. All of the studies cited above were conducted in extremely controlled conditions, where an entire team of people monitored the subjects before, during and after giving them psilocybin.